Position history for BlackRock, Inc.'s holdings in Supernus Pharmaceuticals Inc
BlackRock, Inc. holds 8.8M shares of SUPN (Supernus Pharmaceuticals Inc), worth $454.7M as of 2026-Q1. The position was increased (+0.7% shares). SUPN represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$454.7M
Current Shares
8.8M
Total Value Change
+$93.2M
Total Shares Change
-1.2M
Other major holders of SUPN: BlackRock Finance, Inc., VANGUARD GROUP INC
Increased |
| 8.8M |
+0.7% |
| $454.7M |
| 0.0% |
| $54.56 |
31 |
| 2025-Q4 | Increased | 8.7M | +0.4% | $434.2M | 0.0% | $49.89 | 31 |
| 2025-Q3 | Decreased | 8.7M | -7.2% | $415.7M | 0.0% | $47.60 | 0 |
| 2025-Q2 | Decreased | 9.4M | -3.3% | $295.3M | 0.0% | $31.16 | 0 |
| 2025-Q1 | Decreased | 9.7M | -3.1% | $317.2M | 0.0% | $32.29 | 0 |
| 2024-Q4 | New | 10M | - | $361.5M | 0.0% | $36.91 | 43 |